LENTECHS logo — Developing a new generation of soft, suspended contact lens

LENTECHS

Developing a new generation of soft, suspended contact lens

Founded 2020 United States Columbus, United States 9 employees Series Unknown Total: $11.07M Biotechnology, Health Care +1

General Information

Company Name LENTECHS
Founded Year 2020
Location United States Columbus, United States +1
Employees 9
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series Unknown
Social

Get notified when LENTECHS moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About LENTECHS

LENTECHS, LLC is a privately-held, clinical stage ophthalmic medical device company that aims to revolutionize the contact lens industry with its new generation of soft, suspended contact lens. APIOC™, the flagship contact lens platform, features a patented design for suspension of the lens from behind the upper eyelid, based on the anatomy of the eye. Founded in 2017 by optometrist inventors Melissa Bailey, OD, PhD and Joe Barr, OD, MS, FAAO, LENTECHS has successfully developed its core technology licensed from The Ohio State University. The company is set to launch APIOC for Presbyopia and APIOC for Presbyopia with Astigmatism in early-2022, offering presbyopic individuals the possibility of achieving glasses-like vision with the freedom of a soft contact lens. LENTECHS, headquartered in Columbus, Ohio, has garnered significant support from a network of investors committed to pushing the boundaries of innovation in contact lenses. The most recent $6.00M Venture Round investment on 24 October 2023 involved notable backers including Rev1 Ventures, Ohio Innovation Fund, Bluestem Capital, and the JobsOhio Growth Capital Fund. With its groundbreaking technology and strong financial backing, LENTECHS is poised to make a significant impact in the fields of biotechnology and healthcare.

Taxonomy: ophthalmic medical device, contact lens technology, presbyopia, astigmatism, eye health, innovation, optometry, startup, clinical stage company, investors, innovative technology, ophthalmology, vision correction, medical innovation

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 4
Investor Investor Investor Investor
24 Oct 2023
Venture Round •••••• - 08 Feb 2023
Debt Financing •••••• - 16 Nov 2021
Debt Financing •••••• - 13 Apr 2020
Seed Round •••••• 2
Investor Investor
22 Mar 2018

LENTECHS Alternatives & Competitors

LENTECHS vs
SynergEyes, Inc.
SynergEyes, Inc. United States

SynergEyes is a leading expert in specialty contact lenses for both Normal and Irregular Corneal Con...

Unknown
53 employees
Health Care, Manufacturing
LENTECHS vs
PowerVision, Inc.
PowerVision, Inc. United States

Restoring True Vision for All Distances

Series D
13 employees
Biotechnology, Health Care
LENTECHS vs

CooperVision Specialty EMEA

105 employees
Fashion, Manufacturing

FAQ About LENTECHS

Developing a new generation of soft, suspended contact lens
LENTECHS was founded in 2020.
LENTECHS is headquartered in Columbus, United States.
LENTECHS operates in the following industries: Biotechnology, Health Care, Medical Devices.
LENTECHS has approximately 9 employees.
LENTECHS has completed 5 funding rounds, raising a total of $11.07M. The latest funding stage is Series Unknown.
Top alternatives and competitors to LENTECHS include SynergEyes, Inc., PowerVision, Inc., CooperVision Specialty EMEA, Yolia Health, Bend Labs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LENTECHS and SynergEyes, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors LENTECHS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy